At present, transient elastography and the serum marker FibroTest are the most intensively evaluated non-invasive methods for the assessment of liver fibrosis. The results of the present study for ...
Progression from F3 to cirrhosis occurred in roughly one year, contrasting STELLAR’s 13% over four years and suggesting trials may underrepresent real-world risk. Among compensated cirrhosis, 29.7% ...
Hepta, a liquid biopsy company developing blood tests for chronic disease, today announced clinical data showing its blood test more accurately identifies metabolic dysfunction-associated ...
The largest liver study in the history of the NHS has launched this week, aiming to detect liver disease at an early stage so treatment can begin before it progresses to cirrhosis. Around 70% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results